Preparation and Characterization of Large Unilamellar Vesicles Mixed With Trimethylchitosan (TMC): The Effect of Polyelectrolyte Concentration

Preparation and Characterization of Large Unilamellar Vesicles Mixed With Trimethylchitosan (TMC): The Effect of Polyelectrolyte Concentration

The Open Biotechnology Journal 13 Aug 2018 LETTER DOI: 10.2174/1874070701812010134



The effect of different concentrations of the absorption enhancer Trimethyl Chitosan (TMC) to the physicochemical properties of Large Unilamellar Vesicles (LUV) comprised of L-a-Phospahtidyl Choline (PC) were investigated in the current study.


The Degree of Quartenization (DQ) of trimethylchitosan was assessed with nuclear magnetic resonance (1H NMR). The vesicles were characterized by means of Dynamic Light Scattering (DLS), ζ-potential, Differential Scanning Calorimetry (DSC) and Contact Angle Goniometry (CAG) measurements.


The data showed that the surface charge of the PC liposomes was significantly altered as a function of the TMC concentration, giving evidence of presence of the polyelectrolyte to the liposome’s membrane. Varying the concentration of TMC affected the phase Transition Temperature (Tm) of the lipid, verifying the miscibility of the polyelectrolyte with the lipid bilayer. The association of the polymer with the liposomes was related to the amount of the polyelectrolyte present, reflecting changes to the wettability of the dispersion as measured by CAG.


The results demonstrated that presence of TMC significantly modified the physical properties of liposomes. Such systems might have a potential use for mucosal delivery (e.g. nasal route of administration).

Keywords: Large unilamellar vesicles, Trimethylchitosan, Dynamic Light Scattering (DLS), ζ-potential, Differential Scanning Calorimetry (DSC), Contact Angle Goniometry (CAG).


The use of colloidal drug delivery systems, such as nanoparticles and liposomes, has been shown to increase the bioavailability of administered drugs (REF). Liposomes, which are vesicles, composed of one or more phospholipid bilayers can carry a variety of molecules with therapeutic potential and offer different advantages for many routes of administration [1]. Furthermore, liposomes decorated with polyelectrolytes, alter their properties, are extensively used as drug carriers [2, 3] and have been shown to increase their therapeutic activity and circulation lifetime in a biological milieu [4]. By combining chitosan and liposomal characteristics, specific, prolonged, and controlled release can be achieved [5-7]. A solid polymeric vesicle, namely palmitoyl glycol chitosan, was entrapped within a liposomal formulation to control the release profiles of a model compound [8]. A small degree of mixing of the lipids occurred upon hydration of the lipid/surfactant film, resulting in a vesicle formulation instead of a vesicle in vesicle system [8]. The results showed that the polymeric vesicle phospholipid in vesicle system released 28% of the entrapped model compound compared to 62% from the polymeric vesicles over the duration of 4 hours [8].

The presence of chitosan can also enhance the mucoadhesive properties of liposomes. The extent of in vitro mucoadhesion of liposomes coated with different polymers, including chitosan, and carbopol, has been reported previously [9]. The results suggested that chitosan-coated liposomes had the highest percentage of mucoadhesion, followed by carbopol, where no adhesive percentage was observed for the non-coated liposomes [8]. This indicates that the polymer physically interpenetrates the mucin layer in order to facilitate liposome adherence. In a previous report the effect of concentration and different molecular weight of TMC to liposomes containing Coenzyme Q10 was investigated [10]. In the recent studies TMC derivatives co-formulated with liposomes were utilized for ocular deliver of vitamin A palmitate [11], nasal delivery of BSA [12], oral absorption of calcitonin and curcumin [13, 14]. The existence of a polymer layer on the surface of the formulation was confirmed by means of electron microscopy and was associated with changes in particle size diameter and zeta (ζ) potential values. In the current study, Large Unilamellar Vesicles (LUV) with variable TMC (N-trimethyl chitosan) concentration were prepared by the thin-film hydration method and the resulting colloidal dispersions were characterized by means of Dynamic Light Scattering (DLS), ζ-potential measurements, Differential Scanning Calorimetry (DSC), and Contact Angle Goniometry studies (CAG).


2.1. TMC Synthesis

TMC was synthesized from high viscosity chitosan as described previously [11]. 1H-NMR was used to characterize the synthesized TMC polymer. The 1H-NMR spectrum was recorded in D2O with a Bruker 600 MHz spectrometer (Bruker, Faellanden, Switzerland) at 80°C. Minimum interference was observed from the water peak at this temperature and suppression of the water peak was not necessary.

2.2. Preparation and Characterization of TMC/LUV Liposomes

Several approaches have been employed for the formation large vesicles. In a recent study large vesicles were formed combining an electric field and calcium ions [15]. Large Unilamellar Vesicles (LUV), containing TMC, consisted from L-a-Phosphatidyl Choline (PC) (Avanti Lipids, Alabama US) were prepared as has been previously described [16]. Briefly, 13 μmol of the lipid (PC) was dissolved in chloroform in a spherical flask. The organic solvent was removed in a rotary evaporator and the thin film was rehydrated with 2 mL of PBS pH 7.4 containing different amounts of TMC (0, 0.25, 0.50 and 1% w/v respectively). Highly purified water (18.2 MΩ.cm) was used for the preparation of all the solutions. The dispersion was subjected to temperature controlled (20 oC) bath sonication for 20 minutes. The LUV were prepared by extrusion through two stacked polycarbonate filters of 0.4 μm pore size (Nucleopore, Corning Costar Corp., MA, USA) under nitrogen pressure 30 psi.

2.3. Dynamic Light Scattering (DLS) and ζ-Potential Studies

The size distribution (mean diameter and polydispersity index) and the zeta (ζ) potential of the liposomes were measured by DLS on a ZetasizerNano-ZS (Malvern Instruments Ltd., UK), which enabled to obtain the mass distribution of particle size as well as the electrophoretic mobility. Measurements were made at 25 °C with a fixed angle of 137 °. Samples for three different batches were measured.

2.4. Differential Scanning Calorimetry (DSC) Studies

Thermal analysis of the formulations was performed using a Perkin Elmer calorimeter (Perkin Elmer Diamond DSC) in a nitrogen atmosphere. Samples consisted of a 30 μL of liposome suspension in PBS buffer were placed in standard aluminium DSC pans of 40 μL with a pierced lid at a heating scan rate of 2 oC/min.

2.5. Contact Angle Goniometry (CAG) Studies

Advancing (θA) contact angles of small drops (2 μL) at 20 °C were measured using a goniometer with an enclosed thermostated cell (Kruss G10, Hamburg, Germany). The contact angles of droplets (× 3) placed on the horizontal PMMA (× 2) and were obtained for both ‘left’ and ‘right’ contact after approximately 15 s after the initial drop-surface contact. PMMA was used as a model substrate because its surface free energy is a reasonable estimate for hydrophobic compounds which are known to have problematic wetting.


3.1. Characterization of TMC

A yield of 67% was obtained with the synthesis). The polymer synthesised was characterised by 1H-NMR to determine the degree of quarternization, which indicates the percentage of N-groups methylated to quaternary ammonium groups. The degree of substitution was 21.2% which falls within the range typically observed for a one step synthesis reported previously [17].

3.2. Size Distribution and ζ-Potential Data

The effect of different amounts of TMC on the particle size of PC liposomes is illustrated in Fig. (1A). The particle size of TMC-PC liposomes is decreased with increasing concentration of polymer solution. More specifically, the particle size of plain liposomes decreased from 350 to 150 nm with the addition of 0.25% w/v TMC, followed by a decrease to 115 nm and 150 nm when 0.5% and 1% w/v of TMC were added, respectively. The Polydispersity Index (PDI) values for 0, 0.25%, 0.5% and 1% were respectively 0.157, 0.198, 0.245 and 0.259, respectively. This is suggestive of interaction between the polymer and the lipid bilayer (Fig. 1A). The electrical properties of the liposomes in the presence of TMC were assessed by means of ζ-potential measurements. The ζ-potential values for both formulations are shown in (Fig. 2B). PC is a zwitterionic lipid with no net charge [18] while TMC at pH 7.4 is positively charged due to the quaternary ammonium groups. An increase to the ζ-potential values of the PC formulation from -0,65 mV (plain liposomes) to 8.46 mV (1% w/v TMC) was observed after increasing the amount of polyelectrolyte, indicating the incorporation of the polymer in the vesicles’ structure, possible as a layer on the surface of the vesicles.

The relative low values of ζ-potential measured for the liposomal formulations could be attributed to the high ionic strength of the buffer (PBS, pH 7.4) which suppresses the thickness of the electric double layer of the vesicles [18].

3.3. DSC and CAG Studies

To further investigate the interactions of the produced vesicles DSC and contact angle goniometry were employed. The miscibility of TMC with PC liposomes was assessed by means of DSC. Plain PC liposomes have a clear endotherm transition peak at Tm = -10,6°C (Fig. 2A), which is in line with values reported previously [19]. This suggests that the presence of TMC induced changes to the main Transition Temperature, Tm, of the liposomes. More specifically, when 0.25% w/v of TMC was added to vesicles, the Tm was dramatically decreased from -10.8°C to -18.5°C, and was further decreased to -19.3°C and -18.9°C when 0.5% w/v and 1% w/v of TMC was respectively present in the membrane an indication of the miscibility of polyelectrolyte with the phospholipid (Fig. 2A). The main transition is shifted by the presence of TMC in both formulations due to a change, from a gel-like to a liquid-like packing, of the hydrophobic tails of the lipids [20]. That suggests that the packing of the lipids is disturbed within the bilayer; i.e. their order is reduced. This can be attributed to the penetration of the polyelectrolyte into the lipid bilayers. The changes noticed with PC liposomes advocating that the length of the fatty acyl chain seems to play a role on the localization of the polyelectrolyte into the membrane. In an attempt to investigate the potential changes of the lipophilic character of the liposomes upon the addition of the polyelectrolyte, Contact Angle Goniometry (CAG) studies were performed. Fig. (2B) illustrates the CAG values obtained for TMC-PC and liposomes as a function of the polyelectrolyte concentration. In the PC formulation, the θ° value of plain liposomes is increased significantly from 63.42 to 72 (t-test p<0.05) when 0.25% of the polyelectrolyte was added to the vesicles indicating that TMC is located in the lipid bilayer. However, the contact angle values declined up to 55.75 after the addition of high concentrations of TMC (1% w/v). The significantly lower CAG values, compared with the control (t-test p<0.001), confirm the presence of hydrophilic moieties of the polyelectrolyte (TMC) to the surface of liposomes.

Fig. (1). The effect of different TMC concentration on (A.) the size of TMC-coated liposomes in PBS pH 7.4, (B.) the ζ-potential of TMC-coated liposomes in PBS pH 7.4. The results are the mean of three different experiments.
Fig. (2). (A.) DSC thermogramm of TMC-PC liposomes, (B.) Contact angle goniometry values of TMC-PC liposomes. The results are the mean of three different experiments.


The current results emphasize that the amount of the polyelectrolyte that is present in the liposomes’ structure can affect the physicochemical properties of the resulted vesicles. TMC has extensively been used as an absorption enhancer for peptide and protein drugs and possesses mucoadhesive properties [21]. Mixed liposomes with TMC might be a beneficial approach for mucosal delivery (e.g. nasal administration).


Not applicable.


No Animals/Humans were used for studies that are base of this research.


Not applicable.


The authors declare no conflict of interest, financial or otherwise.


Declared none.


Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4(2): 145-60.
Quemeneur F, Rinaudo M, Pépin-Donat B. Influence of polyelectrolyte chemical structure on their interaction with lipid membrane of zwitterionic liposomes. Biomacromolecules 2008; 9(8): 2237-43.
Quemeneur F, Rammal A, Rinaudo M, Pépin-Donat B. Large and giant vesicles “decorated” with chitosan: Effects of pH, salt or glucose stress, and surface adhesion. Biomacromolecules 2007; 8(8): 2512-9.
Takeuchi H, Thongborisute J, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev 2005; 57(11): 1583-94.
Guo J, Ping Q, Jiang G, Huang L, Tong Y. Chitosan-coated liposomes: Characterization and interaction with leuprolide. Int J Pharm 2003; 260(2): 167-73.
Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res 1996; 13(6): 896-901.
Huang YZ, Gao JQ, Liang WQ, Nakagawa S. Preparation and characterization of liposomes encapsulating chitosan nanoparticles. Biol Pharm Bull 2005; 28(2): 387-90.
McPhail D, Tetley L, Dufes C, Uchegbu IF. Liposomes encapsulating polymeric chitosan based vesicles: A vesicle in vesicle system for drug delivery. Int J Pharm 2000; 200(1): 73-86.
Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release 2003; 86(2-3): 235-42.
Zhang J, Wang S. Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: Tolerance, precorneal retention and anti-cataract effect. Int J Pharm 2009; 372(1-2): 66-75.
He W, Guo X, Feng M, Mao N. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels. Int J Pharm 2013; 458(2): 305-14.
Chen KH, Di Sabatino M, Albertini B, Passerini N, Kett VL. The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA. Eur J Pharm Sci 2013; 50(3-4): 312-22.
Huang A, Su Z, Li S, et al. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers. Drug Deliv 2014; 21(5): 388-96.
Chen H, Wu J, Sun M, et al. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin. J Liposome Res 2012; 22(2): 100-9.
Tao F, Yang P. Ca-mediated electroformation of cell-sized lipid vesicles. Sci Rep 2015; 7(5): 9839.
Szoka F, Olson F, Heath T, Vail W, Mayhew E, Papahadjopoulos D. Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta 1980; 601(3): 559-71.
Wise AJ, Smith JR, Bouropoulos N, Yannnopoulos SN, van der Merwe SM, Fatouros DG. Single-wall carbon nanotube dispersions stabilised with N-trimethyl-chitosan. J Biomed Nanotech 2008; 4(1): 67-72.
Jones MN. The surface properties of phospholipid liposome systems and their characterisation. Adv Colloid Interface Sci 1995; 54: 93-128.
Koynova R, Caffrey M. Phases and phase transitions of the phosphatidyl cholines. Biochim Biophys Acta 1998; 1376(1): 91-145.
McElhaney RN. The use of differential scanning calorimetry and differential thermal analysis in studies of model and biological membranes. Chem Phys Lipids 1982; 30(2-3): 229-59.
van der Merwe SM, Verhoef JC, Verheijden JH, Kotzé AF, Junginger HE. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm 2004; 58(2): 225-35.